NO995160L - Fremgangsmåte for fremstilling av overflate metall trikarbonylforbindelser og deres bruk i merking av biologisk aktive substrater - Google Patents

Fremgangsmåte for fremstilling av overflate metall trikarbonylforbindelser og deres bruk i merking av biologisk aktive substrater

Info

Publication number
NO995160L
NO995160L NO995160A NO995160A NO995160L NO 995160 L NO995160 L NO 995160L NO 995160 A NO995160 A NO 995160A NO 995160 A NO995160 A NO 995160A NO 995160 L NO995160 L NO 995160L
Authority
NO
Norway
Prior art keywords
preparation
compound
water
biologically active
surface metal
Prior art date
Application number
NO995160A
Other languages
English (en)
Other versions
NO995160D0 (no
Inventor
Roger Alberto
Roger Schibli
Andre Egli
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of NO995160D0 publication Critical patent/NO995160D0/no
Publication of NO995160L publication Critical patent/NO995160L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G45/00Compounds of manganese
    • C01G45/04Carbonyls
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G99/00Subject matter not provided for in other groups of this subclass
    • C01G99/006Compounds containing, besides a metal not provided for elsewhere in this subclass, two or more other elements other than oxygen or hydrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/88Isotope composition differing from the natural occurrence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995160A 1997-04-25 1999-10-22 Fremgangsmåte for fremstilling av overflate metall trikarbonylforbindelser og deres bruk i merking av biologisk aktive substrater NO995160L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201232A EP0879606A1 (en) 1997-04-25 1997-04-25 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
PCT/US1998/007979 WO1998048848A1 (en) 1997-04-25 1998-04-21 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates

Publications (2)

Publication Number Publication Date
NO995160D0 NO995160D0 (no) 1999-10-22
NO995160L true NO995160L (no) 1999-12-13

Family

ID=8228251

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995160A NO995160L (no) 1997-04-25 1999-10-22 Fremgangsmåte for fremstilling av overflate metall trikarbonylforbindelser og deres bruk i merking av biologisk aktive substrater

Country Status (18)

Country Link
EP (2) EP0879606A1 (no)
JP (1) JP4357597B2 (no)
KR (1) KR100579168B1 (no)
AT (1) ATE211924T1 (no)
AU (1) AU748213B2 (no)
BR (1) BR9809409B1 (no)
CA (1) CA2282563C (no)
CZ (1) CZ295214B6 (no)
DE (1) DE69803205T2 (no)
DK (1) DK1019095T3 (no)
ES (1) ES2168751T3 (no)
HU (1) HU225487B1 (no)
IL (1) IL131658A (no)
NO (1) NO995160L (no)
NZ (1) NZ337303A (no)
PL (1) PL189514B1 (no)
PT (1) PT1019095E (no)
WO (1) WO1998048848A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19860289C2 (de) 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
EP1021074B1 (en) 1999-01-15 2012-06-20 The Boeing Company Solid state flight deck panels and components thereof
US6844425B1 (en) 1999-02-24 2005-01-18 Mallinckrodt Inc. Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
AU3282300A (en) * 1999-02-24 2000-09-14 Mallinckrodt, Inc. Molecules for the treatment and diagnosis of tumors
CZ20014603A3 (cs) * 1999-06-29 2002-11-13 Mallinckrodt Inc. Pouľití aminopolykarboxylátových ligandů při značení biologicky aktivních substrátů Tc-99m-trikarbonylovými prekurzory
US6926883B1 (en) * 1999-06-29 2005-08-09 Mallinckrodt Inc Group (VII) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
AUPQ262499A0 (en) 1999-09-02 1999-09-23 University Of Queensland, The Novel iron chelators
ES2320407T3 (es) 1999-10-05 2009-05-22 Mallinckrodt Inc. Fuente de monoxido de carbono para la preparacion de complejos de metal de trasnsicion y carbonilo.
US6359119B1 (en) * 2000-05-24 2002-03-19 Mallinckrodt Inc. Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
CA2410906C (en) * 2000-06-02 2012-10-02 Board Of Regents, The University Of Texas System Ethylenedicysteine (ec)-drug conjugates
CN1136921C (zh) * 2001-04-27 2004-02-04 北京师范大学 一种心肌显像剂及其制备方法
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7011854B2 (en) 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
KR100445971B1 (ko) * 2002-04-15 2004-08-25 한국원자력연구소 수소화붕소 교환수지를 이용한 테크네튬 또는 레늄의표지방법
CA2497548A1 (en) * 2002-09-03 2004-03-18 University Of Zurich Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
KR20050119694A (ko) 2003-04-15 2005-12-21 말린크로트, 인코포레이티드 Re 및 Tc 트리카르보닐 착체에 대한 리간드를 함유하는이관능성 세자리 피라졸릴
US7682601B2 (en) 2003-04-15 2010-03-23 Mallinckrodt Inc. Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
CN100507563C (zh) * 2003-04-29 2009-07-01 苏黎世大学 借助通过fac配位作用高效标记[M(OH2)3(CO)3]+而用于偶联生物分子的Nε和/或Nα衍生化的、金属和有机保护的L-组氨酸
US20060051291A1 (en) * 2004-09-07 2006-03-09 Adam Michael J Synthesis of radiolabeled sugar metal complexes
JP2008037752A (ja) * 2004-11-19 2008-02-21 Nihon Medi Physics Co Ltd 新規放射性テクネチウム−ビスホスフィノアミン錯体および該錯体を含む放射性画像診断剤
KR100650506B1 (ko) * 2005-12-16 2006-11-30 한국원자력연구소 방사성 의약품용 레늄-트리카보닐 착물 및 그 전구체의제조방법
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
GB0623482D0 (en) 2006-11-24 2007-01-03 Mallinckrodt Inc Technetium-99m (l) tricarbonyl complexes with tridentate chelators for myocardium imaging
DE102010014411A1 (de) 2010-04-08 2011-10-13 Friedrich-Schiller-Universität Jena Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
DE102010014412A1 (de) 2010-04-08 2012-04-19 Friedrich-Schiller-Universität Jena Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe
PT2699242T (pt) 2011-04-19 2018-01-22 Alfama Inc Moléculas de libertação de monóxido de carbono e utilizações das mesmas
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
DE102012004132A1 (de) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung
KR101200049B1 (ko) * 2012-05-14 2012-11-13 한국원자력연구원 테크네튬-99엠 트리카보닐 표지 글리신 단량체 또는 올리고머 활용 생리활성분자를 이용한 프로브의 제조방법 및 이를 포함하는 영상제 조성물
DE102014008537A1 (de) 2014-06-04 2015-12-17 Friedrich-Schiller-Universität Jena Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
RU2708076C1 (ru) * 2019-09-10 2019-12-04 федеральное государственное автономное образовательное учреждение высшего образования «Национальный исследовательский Томский политехнический университет» Способ получения комплекса технеция-99м с производным октреотида для диагностики нейроэндокринных опухолей

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533570B1 (fr) * 1982-09-23 1985-07-12 Centre Nat Rech Scient Complexes organometalliques d'oestrogenes et leur application au dosage des recepteurs hormonaux

Also Published As

Publication number Publication date
NO995160D0 (no) 1999-10-22
PL189514B1 (pl) 2005-08-31
KR100579168B1 (ko) 2006-05-12
EP1019095B1 (en) 2002-01-16
JP2002512616A (ja) 2002-04-23
AU748213B2 (en) 2002-05-30
EP0879606A1 (en) 1998-11-25
DE69803205T2 (de) 2002-09-19
PT1019095E (pt) 2002-07-31
CA2282563C (en) 2007-12-04
HUP0003255A3 (en) 2003-06-30
BR9809409B1 (pt) 2008-11-18
ES2168751T3 (es) 2002-06-16
HU225487B1 (en) 2006-12-28
WO1998048848A1 (en) 1998-11-05
IL131658A0 (en) 2001-01-28
KR20010020298A (ko) 2001-03-15
IL131658A (en) 2004-12-15
PL336382A1 (en) 2000-06-19
CZ295214B6 (cs) 2005-06-15
CA2282563A1 (en) 1998-11-05
NZ337303A (en) 2000-12-22
DK1019095T3 (da) 2002-05-06
DE69803205D1 (de) 2002-02-21
HUP0003255A2 (hu) 2001-02-28
AU7141398A (en) 1998-11-24
BR9809409A (pt) 2000-06-13
ATE211924T1 (de) 2002-02-15
EP1019095A1 (en) 2000-07-19
CZ9903751A3 (en) 2001-05-16
JP4357597B2 (ja) 2009-11-04

Similar Documents

Publication Publication Date Title
NO995160D0 (no) Fremgangsmåte for fremstilling av overflate metall trikarbonylforbindelser og deres bruk i merking av biologisk aktive substrater
Chakravarty et al. Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard
US6126916A (en) Radiometal-binding peptide analogues
US5180816A (en) One vial method for labeling protein/linker conjugates with technetium-99M
US5218128A (en) Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
JPH07103159B2 (ja) 放射性核種金属キレート
JACOBSON et al. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1, 3-dipropylxanthine
KR20090096597A (ko) [f-18]-표지된 l-글루탐산, [f-18]-표지된 l-글루타민, 이들의 유도체 및 이들의 용도 및 이들의 제조 방법
JPS58116443A (ja) 新規ペプチドおよびその製法
Zarezin et al. Diazocarbonyl derivatives of amino acids: unique chiral building blocks for the synthesis of biologically active compounds
Bentley et al. Qualitative determination of N-terminal amino acids of peptides and proteins with cobalt (III) chelates
CA2019035C (en) Stabilized radiopharmaceutical compositions
Kornguth et al. The Stability and Rearrangement of iε-N-Glutamyl-Lysines
AU722595B2 (en) Urethane mediated, GST specific molecular release systems
US5144043A (en) Cleavable bifunctional coupling agents
Tobe et al. Synthesis and structure-activity relationships of amastatin analogues, inhibitors of aminopeptidase A
Sauvé et al. Carboxyl-modified amino acids and peptides: II) A convenient route for the synthesis of difunctionalized enamines from thioamides via thioiminium salts
Okarvi et al. Comparison of the labelling characteristics of mercaptoacetyltriglycine (MAG3) with different S‐protective groups
ATE82130T1 (de) Verfahren zum affinitaetschromatografischen reinigen von faktor xiii.
Hofmann et al. Radioactive probes for adrenocorticotropic hormone receptors
JPH02503006A (ja) 医薬作用を有するプリン誘導体
Leighton et al. Amino Acid Sequences Containing Cysteine or Half-Cystine Residues in ß-Glucuronidase
JP2680080B2 (ja) 新規カルシトニン誘導体
SANO Chemical synthesis of the cytochrome c molecule
Wunderlin et al. Melanotropin Receptors I. Synthesis and Biological Activity of Nα‐(5‐Bromovaleryl)‐Nα‐deacetyl‐α‐melanotropin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application